INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
$1K reward offered for missing service dog
A west-side family is offering a $1,000 reward for help finding their missing service dog.
WATCH LIVE: Press conference on WDBJ shooting
3 people found dead in Henry Co. home
Henry County officials are investigating after at least two people were found dead in a home.
Cut gas line closes Fry Road in Greenwood
Fry Road in Greenwood is closed from U.S. 31 to State Road 135 after a gas line was cut.
CALL 6: FDA not disclosing drug's side effects
The U.S. Food & Drug Administration is failing to disclose additional serious side effects associated with one of the most popular and…